Large-scale testing (Phase 3)Looking for participantsNCT07500506
What this trial is testing
Learn About the Safety, Tolerability, and Immunogenicity of a Fifth Dose of 6-Valent OspA-Based Lyme Disease Vaccine
Who this might be right for
Lyme Disease
Pfizer 1,712